Genmab — Juli 2022

[Rondo]

Nogen der ved hvorfor gmab er så stærk i dag... er der noget und opsejling ?

[nohope]

Det er fordi det er pissekoldt at stå på græsplænen og drikke champagne i december måned.

[Stroka]

Rondo..Måske fordi Helge omtalte aktien meget positivt her. https://proinvestor.com/boards/104621/

[Rondo]

@nohope ... du har mange goo men lige den sidste gav ingen mening...

[Rondo]

@stroka arg..... Helge kan meget ...men men

[JKY_VH]

Rondo, det er måske fordi at der er en iboende tendens til, at fornuften vinder på sigt;-)

[E_L]

we have Teclistamab on the CHMP agenda this week, that could have received a positive recommendation; we simple people will hear in a few hours. And bund yields falling further again; 1.07% atm

[E_L]

10y yield

[JKY_VH]

Er det nu blevet champagne? Jeg forstod ellers, at du havde sendt din bedre halvdel i Netto efter 6 liter sprudelwasser på tilbud;-)

[nohope]

Danskvand med citronsmag ved kurs 2500. Champagne ved 3000. Forvent at det bliver cremant da ægte champagne smager af tørt rugbrød.

[E_L]

EMA Orphan designation: Teclistamab for the: Treatment of multiple myeloma, 19/07/2022, Withdrawn (updated) -any idea why JNJ would do that? Any disadvantages for commercialisation i am unaware off?

[E_L]

Positive opinion granted! There is your good news for the friday

[Helge_LarsenPI-redaktør]

Thanks E L .

[E_L]

The bad news is the new name, Tecvayli, ffs who makes these up

[E_L]

Page or document not found | European Medicines Agency (EMA)

We are sorry, but the content you tried to access is unavailable at the link you used, which was either incorrect or out-of-date. To help you find what you are looking for, we have included some useful tips.

European Medicines Agency (EMA) (www.ema.europa.eu)

[Stroka]

Ingen reaktion på aktiekursen.

[Sukkeralf]

E L regarding the ODD withdrawned it could be due to the marked size being bigger than expected.

[deleted-user]

Thx E L you never disappoint likewise Genmab

[E_L]

Thx. OK, thx, I was thinking in the same direction Sukkeralf. I am even thinking, IF they would broaden the indication outside of myeloma at some point, and that way reach more patients in total, if they would then loose orphan for myeloma anyway

[E_L]

But anyway, who cares, product #6 on it's way